# Indication of Permanent Cardiac Parcing After Tanscatheter Aortic Valve Implantation

Study · id `cardio:ct-nct02337140` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02337140](<https://clinicaltrials.gov/study/NCT02337140>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02337140

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 165 participants.

## Technical summary

Registry record NCT02337140. Non-randomized; no masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2016-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 165 participants (enrolled count; ClinicalTrials.gov record NCT02337140, source copy `cardio:ctgov-nct02337140-2016-12-01`, retrieved 2026-10-26)
- Start date: 2014-08 (registry gives no type) (ClinicalTrials.gov record NCT02337140, source copy `cardio:ctgov-nct02337140-2016-12-01`, retrieved 2026-10-26)
- Primary completion: 2016-04 (actual) (ClinicalTrials.gov record NCT02337140, source copy `cardio:ctgov-nct02337140-2016-12-01`, retrieved 2026-10-26)
- Completion: 2016-08 (actual) (ClinicalTrials.gov record NCT02337140, source copy `cardio:ctgov-nct02337140-2016-12-01`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT02337140, source copy `cardio:ctgov-nct02337140-2016-12-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02337140-2016-12-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Indication of Permanent Cardiac Parcing After Tanscatheter Aortic Valve Implantation
- Acronym: TAVISTIM
- Condition: Aortic Valve Stenosis
- Intervention (Device): Pacemaker SORIN Group KORA DR
- Intervention (Procedure): transcatheter aortic valve implantation (TAVI)
- Lead sponsor: University Hospital, Montpellier
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: University Hospital, Montpellier (`cardio:org-university-hospital-montpellier`)

## Provenance

Content hash: 3106b2e544bb184ffc4773f40b7a1815a35c78bf61081d5eb066fff2635fc681
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
